Investor Alert

New York Markets Open in:

23andMe Holding Co.



Before the Bell

 --Real time quotes

Feb 2, 2023, 9:27 a.m.





+0.11 +4.30%


Volume 55,341

Real time quotes


Previous close

$ 2.56

$ 2.56


+0.06 +2.40%

Day low

Day high




52 week low

52 week high




Richard H. Scheller

Richard H. Scheller holds the position of Chairman of DiCE Therapeutics, Inc, Chairman of DICE Molecules SV, Inc. (a subsidiary of DiCE Therapeutics, Inc) and Director, Chairman-Research & Development at BridgeBio Pharma, Inc., Director, Chairman-Research & Development at BridgeBio Pharma LLC (a subsidiary of BridgeBio Pharma, Inc.). Dr. Scheller is also Member of National Academy of Sciences, Member of American Academy of Arts & Sciences and Member of National Academy of Medicine (United States) and on the board of 8 other companies.

Dr. Scheller previously was Head-Genentech Research & Early Development at Roche Holding AG and Executive VP, Head-Research & Early Development at Genentech, Inc. (a subsidiary of Roche Holding AG), Director & Chief Scientific Officer at Medrio, Inc. and Professor at Stanford University.

He received a doctorate from California Institute of Technology, a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Wisconsin.


Date Shares Transaction Value
11/11/2022 18,421   Disposition at $3.24 per share. 59,685
09/06/2022 14,633   Award at $0 per share. 0
08/25/2022 57,755   Award at $0 per share. 0
09/14/2021 18,421   Award at $0 per share. 0

Officers and Executives

Ms. Anne E. Wojcicki
President, Chief Executive Officer & Director
Mr. Joseph Selsavage
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Ms. Kathy L. Hibbs
Secretary & Chief Administrative Officer
Dr. Kenneth J. Hillan
Chief Therapeutics Officer
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Mr. Kent Hillyer
Vice President-Customer Care
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Chief Operating Officer-Consumer
Mr. Daniel Chu
Chief Product Officer
Mr. Evan M. Lovell
Dr. Richard H. Scheller
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Dr. D. Wade Walke
Vice President-Investor Relations
Ms. Jacquie Cooke Haggarty
General Counsel & Privacy Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie C. Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Mr. Neal Mohan
Independent Director
Link to MarketWatch's Slice.